Oxysterol‐induced osteogenic differentiation of marrow stromal cells is regulated by Dkk‐1 inhibitable and PI3‐kinase mediated signaling
- 8 July 2008
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 105 (2), 424-436
- https://doi.org/10.1002/jcb.21840
Abstract
Osteoporosis and its complications cause morbidity and mortality in the aging population, and result from increased bone resorption by osteoclasts in parallel with decreased bone formation by osteoblasts. A widely accepted strategy for improving bone health is targeting osteoprogenitor cells in order to stimulate their osteogenic differentiation and bone forming properties through the use of osteoinductive/anabolic factors. We previously reported that specific naturally occurring oxysterols have potent osteoinductive properties, mediated in part through activation of hedgehog signaling in osteoprogenitor cells. In the present report, we further demonstrate the molecular mechanism(s) by which oxysterols induce osteogenesis. In addition to activating the hedgehog signaling pathway, oxysterol‐induced osteogenic differentiation is mediated through a Wnt signaling‐related, Dkk‐1‐inhibitable mechanism. Bone marrow stromal cells (MSC) treated with oxysterols demonstrated increased expression of osteogenic differentiation markers, along with selective induced expression of Wnt target genes. These oxysterol effects, which occurred in the absence of β‐catenin accumulation or TCF/Lef activation, were inhibited by the hedgehog pathway inhibitor, cyclopamine, and/or by the Wnt pathway inhibitor, Dkk‐1. Furthermore, the inhibitors of PI3‐Kinase signaling, LY 294002 and wortmanin, inhibited oxysterol‐induced osteogenic differentiation and induction of Wnt signaling target genes. Finally, activators of canonical Wnt signaling, Wnt3a and Wnt1, inhibited spontaneous, oxysterol‐, and Shh‐induced osteogenic differentiation of bone marrow stromal cells, suggesting the involvement of a non‐canonical Wnt pathway in pro‐osteogenic differentiation events. Osteogenic oxysterols are, therefore, important small molecule modulators of critical signaling pathways in pluripotent mesenchymal cells that regulate numerous developmental and post‐developmental processes. J. Cell. Biochem. 105: 424–436, 2008.Keywords
This publication has 65 references indexed in Scilit:
- Zebrafish Naked1 and Naked2 antagonize both canonical and non-canonical Wnt signalingDevelopmental Biology, 2007
- Lifelong accumulation of bone in mice lacking Pten in osteoblastsProceedings of the National Academy of Sciences, 2007
- Statin-induced Ras Activation Integrates the Phosphatidylinositol 3-Kinase Signal to Akt and MAPK for Bone Morphogenetic Protein-2 Expression in Osteoblast DifferentiationPublished by Elsevier BV ,2007
- Dickkopf-1 induced apoptosis in human placental choriocarcinoma is independent of canonical Wnt signalingBiochemical and Biophysical Research Communications, 2006
- Mesenchymal stem cellsAnnals of Medicine, 2005
- Cloning and characterization of the promoter of human Wnt inhibitory factor-1Biochemical and Biophysical Research Communications, 2004
- Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -β-catenin-independent signaling pathwayExperimental Cell Research, 2004
- Requirement of BMP-2-induced Phosphatidylinositol 3-Kinase and Akt Serine/Threonine Kinase in Osteoblast Differentiation and Smad-dependent BMP-2 Gene TranscriptionJournal of Biological Chemistry, 2002
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002
- Characterization of human bone marrow stromal cells with respect to osteoblastic differentiationJournal of Orthopaedic Research, 1997